ArticleFrontiers in immunology2024

Discovery and preclinical evaluation of BPB-101: a novel triple functional bispecific antibody targeting GARP-TGF-β complex/SLC, free TGF-β and PD-L1.

Wenxin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.